Cargando…
Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors: An in vivo and in vitro study
Aberrant DNA methylation is a feature of human cancer affecting gene expression and tumor phenotype. Here, we quantified promoter methylation of candidate genes and global methylation in 44 small intestinal-neuroendocrine tumors (SI-NETs) from 33 patients by pyrosequencing. Findings were compared wi...
Autores principales: | Fotouhi, Omid, Adel Fahmideh, Maral, Kjellman, Magnus, Sulaiman, Luqman, Höög, Anders, Zedenius, Jan, Hashemi, Jamileh, Larsson, Catharina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143414/ https://www.ncbi.nlm.nih.gov/pubmed/24762809 http://dx.doi.org/10.4161/epi.28936 |
Ejemplares similares
-
Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization
por: Hashemi, Jamileh, et al.
Publicado: (2013) -
Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors
por: Fotouhi, Omid, et al.
Publicado: (2016) -
Genetic characterization of large parathyroid adenomas
por: Sulaiman, Luqman, et al.
Publicado: (2012) -
Clinical Routine Application of the Second-generation Neuroendocrine Markers ISL1, INSM1, and Secretagogin in Neuroendocrine Neoplasia: Staining Outcomes and Potential Clues for Determining Tumor Origin
por: Juhlin, Carl Christofer, et al.
Publicado: (2020) -
Metastatic Neuroendocrine Neoplasms of Unknown Primary: Clues from Pathology Workup
por: Juhlin, Carl Christofer, et al.
Publicado: (2022)